Kwan Pui San 4
4 · ChemoCentryx, Inc. · Filed Jan 27, 2021
Insider Transaction Report
Form 4
Kwan Pui San
Principal Acctg Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-25$10.86/sh+1,391$15,106→ 5,457 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-25−1,391→ 16,675 totalExercise: $10.86Exp: 2028-03-05→ Common Stock (1,391 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-01-25−834→ 0 totalExercise: $6.62Exp: 2027-02-28→ Common Stock (834 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-01-25−1,125→ 27,000 totalExercise: $11.02Exp: 2029-03-04→ Common Stock (1,125 underlying) - Exercise/Conversion
Common Stock
2021-01-25$6.62/sh+834$5,521→ 4,066 total - Exercise/Conversion
Common Stock
2021-01-25$11.02/sh+1,125$12,398→ 6,582 total - Sale
Common Stock
2021-01-25$65.00/sh−4,184$271,960→ 3,232 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]As of January 25, 2021, and prior to this transaction, the exercised options were fully vested.
- [F3]Not applicable.